Streptococcus pneumoniae: Infection, inflammation and disease

Advances in Experimental Medicine and Biology

Volumn 582, Issue , 2006, Pages 111-124

  Mitchell, Tim J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934439718     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-33026-7_10     Document Type: Review

References (108)

1. Alcantara, R.B., Preheim, L.C., and Gentry, M.J. (1999) Role of pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats. Infection and Immunity 67: 2862-2866.
2. Alexander, J.E., Lock, R.A., Peeters, C.C., Poolman, J.T., Andrew, P.W., Mitchell, T.J., Hansman, D., and Paton, J.C. (1994) Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun 62: 5683-5688.
3. Alpern, E.R., Alessandrini, E.A., McGowan, K.L., Bell, L.M., and Shaw, K.N. (2001) Serotype prevalence of occult pneumococcal bacteremia. Pediatrics 108: E23.
4. Auzat, I., Chapuy-Regaud, S., Le Bras, G., Dos Santos, D., Ogunniyi, A.D., Le Thomas, I., Garel, J.R., Paton, J.C., and Trombe, M.C. (1999) The NADH oxidase of Streptococcus pneumoniae: its involvement in competence and virulence. Molecular Microbiology 34: 1018-1028.
5. Baba, H., Kawamura, I., Kohda, C., Nomura, T., Ito, Y., Kimoto, T., Watanabe, I., Ichiyama, S., and Mitsuyama, M. (2001) Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins. Biochemical and Biophysical Research Communications 281: 37-44.
6. Benton, K.A., Everson, M.P., and Briles, D.E. (1995) A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infection and Immunity 63: 448-455.
7. Bergmann, S., Wild, D., Diekmann, O., Frank, R., Bracht, D., Chhatwal, G.S., and Hammerschmidt, S. (2003) Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae. Mol Microbiol 49: 411-423.
8. Bergmann, S., Rohde, M., and Hammerschmidt, S. (2004) Glyceraldehyde-3-Phosphate Dehydrogenase of Streptococcus pneumoniae Is a Surface-Displayed Plasminogen-Binding Protein. Infect. Immun. 72: 2416-2419.
9. Berry, A., Alexander, J., Mitchell, T., Andrew, P., Hansman, D., and Paton, J. (1995a) Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect. Immun. 63: 1969-1974.
10. Berry, A.M., Lock, R.A., Hansman, D., and Paton, J.C. (1989a) Contribution of autolysin to virulence of Streptococcus pneumoniae. Infect. Immun. 57: 2324-2330.
11. Berry, A.M., Yother, J., Briles, D.E., Hansman, D., and Paton, J.C. (1989b) Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57: 2037-2042.
12. Berry, A.M., Alexander, J.E., Mitchell, T.J., Andrew, P.W., Hansman, D., and Paton, J.C. (1995b) Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect Immun 63: 1969-1974.
13. Berry, A.M., and Paton, J.C. (2000) Additive Attenuation of Virulence of Streptococcus pneumoniae by Mutation of the Genes Encoding Pneumolysin and Other Putative Pneumococcal Virulence Proteins. Infect. Immun. 68: 133-140.
14. Black, S., Shinefield, H., Fireman, B., Lewis, E., Ray, P., Hansen, J.R., Elvin, L., Ensor, K.M., Hackell, J., Siber, G., Malinoski, F., Madore, D., Chang, I., Kohberger, R., Watson, W., Austrian, R., and Edwards, K. (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19: 187-195.
15. Boulnois, G.J., Mitchell, T.J., Saunders, F.K., Mendez, F.J., and Andrew, P.W. (1990) Structure and function of pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae. In Bacterial Protein Toxins. Rapuoli, R.e.a. (ed): Stuttgart, pp. pp. 43-51.
16. Braun, J.S., Novak, P., Gao, G.L., Murray, P.J., and Shenep, J.L. (1999) Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infection and Immunity 67: 3750-3756.
17. Braun, J.S., Sublett, J.E., Freyer, D., Mitchell, T.J., Cleveland, J.L., Tuomanen, E.I., and Weber, J.R. (2002) Pneumococcal pneumolysin and H2O2 mediate brain cell apoptosis during meningitis. Journal of Clinical Investigation 109: 19-27.
18. Brown, J.S., Gilliland, S.M., and Holden, D.W. (2001) A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence. Mol Microbiol 40: 572-585.
19. Brueggemann, A.B., Griffiths, D.T., Meats, E., Peto, T., Crook, D.W., and Spratt, B.G. (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187: 1424-1432.
20. Brueggemann, A.B., and Spratt, B.G. (2003) Geographic Distribution and Clonal Diversity of Streptococcus pneumoniae Serotype 1 Isolates. J. Clin. Microbiol. 41: 4966-4970.
21. Camara, M., Boulnois, G.J., Andrew, P.W., and Mitchell, T.J. (1994) A neuraminidase from Streptococcus pneumoniae has the features of a surface protein. Infect. Immun. 62: 3688-3695.
22. Canvin, J.R., Marvin, A.P., Sivakumaran, M., Paton, J.C., Boulnois, G.J., Andrew, P.W., and Mitchell, T.J. (1995) The Role of Pneumolysin and Autolysin in the Pathology of Pneumonia and Septicemia in Mice Infected With a Type-2 Pneumococcus. Journal of Infectious Diseases 172: 119-123.
23. Cockeran, R., Steel, H.C., Mitchell, T.J., Feldman, C., and Anderson, R. (2001) Pneumolysin potentiates production of prostaglandin E-2 and leukotriene B-4 by human neutrophils. Infection and Immunity 69: 3494-3496.
24. Cockeran, R., Durandt, C., Feldman, C., Mitchell, T.J., and Anderson, R. (2002) Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis 186: 562-565.
25. Comis, S.D., Osborne, M.P., Stephen, J., Tarlow, M.J., Hayward, T.L., Mitchell, T.J., Andrew, P.W., and Boulnois, G.J. (1993) Cytotoxic effects on hair cells of guinea pig cochlea produced by pneumolysin, the thiol activated toxin of Streptococcus pneumoniae. Acta Otolaryngol 113: 152-159.
26. Crain, M.J., II, W.D.W., Turner, J.S., Yother, J., Talkington, D.F., McDaniel, L.S., Gray, B.M., and Briles, D.E. (1990) Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect Immun 58: 3293-3299.
27. Cundell, D.R., Gerard, N.P., Gerard, C., Idanpaan-Heikkila, I., and Tuomanen, E.I. (1995) Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377: 435-438.
28. Dagan, R., Gradstein, S., Belmaker, I., Porat, N., Siton, Y., Weber, G., Janco, J., and Yagupsky, P. (2000) An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis 30: 319-321.
29. Dave, S., Brooks-Walter, A., Pangburn, M.K., and McDaniel, L.S. (2001) PspC, a Pneumococcal Surface Protein, Binds Human Factor H. Infect. Immun. 69: 3435-3437.
30. de los Toyos, J.R., Mendez, F.J., Aparicio, J.F., Vazquez, F., Del Mar Garcia Suarez, M., Fleites, A., Hardisson, C., Morgan, P.J., Andrew, P.W., and Mitchell, T.J. (1996) Functional analysis of pneumolysin by use of monoclonal antibodies. Infect Immun 64: 480-484.
31. DeMaria, A., Browne, K., Berk, S.L., Sherwood, E.J., and McCabe, W.R. (1980) An outbreak of type 1 pneumococcal pneumonia in a men's shelter. J. American Medical Association 244: 1446-1449.
32. Denny, F.W., and Loda, F.A. (1986) Acute respiratory infections are the leading cause of death in children in developing countries. Am J Trop Med Hyg 35: 1-2.
33. Duane, P.G., Rubins, J.B., Weisel, H.R., and Janoff, E.N. (1993) Identification of hydrogen peroxide as a Streptococcus pneumoniae toxin for rat alveolar epithelial cells. Infection and Immunity: 4392-4397.
34. Eltringham, G., Kearns, A., Freeman, R., Clark, J., Spencer, D., Eastham, K., Harwood, J., and Leeming, J. (2003) Culture-Negative Childhood Empyema Is Usually Due to Penicillin-Sensitive Streptococcus pneumoniae Capsular Serotype 1. J. Clin. Microbiol. 41: 521-522.
35. Ferrante, A., RowanKelly, B., and Paton, J.C. (1984) Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin. Infect. Immun. 46: 585-589.
36. Gillespie, S.H. (1989) Aspects of pneumococcal infection including bacterial virulence, host response and vaccination. J. Med. Microbiol. 28: 237-248.
37. Gosink, K.K., Mann, E.R., Guglielmo, C., Tuomanen, E.I., and Masure, H.R. (2000) Role of novel choline binding proteins in virulence of Streptococcus pneumoniae. Infection and Immunity 68: 5690-5695.
38. Gratten, M., Morey, F., Dixon, J., Manning, K., Torzillo, P., Matters, R., Erlich, J., Hanna, J., Asche, V., and Riley, I. (1993) An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia. Med J Aust 158: 340-342.
39. Gray, B.M., Converse, G.M.I., and Dillon, H.C.J. (1980) Epidemiologic Studies of Streptococcus pneumoniae in Infants: Acquisition, Carriage, and Infection During the First 24 Months of Life. The Journal of Infectious Disease 142: 923-933.
40. Hammerschmidt, S., Bethe, G., H. Remane, P., and Chhatwal, G.S. (1999) Identification of Pneumococcal Surface Protein A as a Lactoferrin-Binding Protein of Streptococcus pneumoniae. Infect. Immun. 67: 1683-1687.
41. Hausdorff, W.P., Bryant, J., Kloek, C., Paradiso, P.R., and Siber, G.R. (2000) The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 30: 122-140.
42. Hausdorff WP, B.J., Paradiso P.R., Siber G.R. (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30: 100-121.
43. Hava, D., and Camilli, A. (2002) Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45: 1389-1406.
44. Henrichsen, J. (1995) Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33: 2759-2762.
45. Henriques Normark, B., Kalin, M., Ortqvist, A., Akerlund, T., Liljequist, B.O., Hedlund, J., Svenson, S.B., Zhou, J., Spratt, B.G., Normark, S., and Kallenius, G. (2001) Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis 184: 861-869.
46. Hirst, R.A., Sikand, K.S., Rutman, A., Mitchell, T.J., Andrew, P.W., and Ocallaghan, C. (2000) Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency. Infection and Immunity 68: 1557-1562.
47. Holmes, A.R., McNab, R., Millsap, K.W., Rohde, M., Hammerschmidt, S., Mawdsley, J.L., and Jenkinson, H.F. (2001) The pavA gene of Streptococcus pneumoniae encodes a fibronectin-binding protein that is essential for virulence. Mol Microbiol 41: 1395-1408.
48. Holtje, J.-V., and Tomasz, A. (1974) Teichoic Acid Phosphorylcholine Esterase. A Novel Enzyme Acivity in Pneumococcus. J. Biol. Chem. 249: 7032-7034.
49. Houldsworth, S., Andrew, P.W., and Mitchell, T.J. (1994) Pneumolysin Stimulates Production of Tumor Necrosis Factor Alpha and Interleukin-1β by Human Mononuclear Phagocytes. Infection and Immunity 62: 1501-1503.
50. Humphrey, J.H. (1948) Hyaluronidase Production by Pneumococci. Journal of Pathology and Bacteriology 55: 273-275.
51. Ispahani, P., Slack, R.C., Donald, F.E., Weston, V.C., and Rutter, N. (2004) Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation. Arch Dis Child 89: 757-762.
52. Janulczyk, R., Iannelli, F., Sjoholm, A.G., Pozzi, G., and Bjorck, L. (2000) Hic, a Novel Surface Protein of Streptococcus pneumoniae That Interferes with Complement Function. J. Biol. Chem. 275: 37257-37263.
53. Jefferies, J.M.C., Smith, A., Clarke, S.C., Dowson, C., and Mitchell, T.J. (2004) Genetic Analysis of Diverse Disease-Causing Pneumococci Indicates High Levels of Diversity within Serotypes and Capsule Switching. J. Clin. Microbiol. 42: 5681-5688.
54. Johnson, M.K. (1979) The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr. Eye Res. 9: 1107-1114.
55. Jonsson, S., Musher, D.M., Chapman, A., Goree, A., and Lawrence, E.C. (1985) Phagoocytosis and Killing of Common Bacterial pathogens of the Lung by Human Alveolar Macrophages. The Journal of Infectious Diseases 152: 4-13.
56. Kalin, M. (1998) Pneumococcal serotypes and their clinical relevance. Thorax 53: 159-162.
57. Kharat, A.S., and Tomasz, A. (2003) Inactivation of the srtA Gene Affects Localization of Surface Proteins and Decreases Adhesion of Streptococcus pneumoniae to Human Pharyngeal Cells In Vitro. Infect. Immun. 71: 2758-2765.
58. Kipli, T., Jokinen, J., Herva, E., Palmu, A., Lockhart, S., Siber, G., Eskola, J., and Group, t.F.O.M.S. (2000) Effect of a heptavalent pneumococcal vaccine (PNCCRM) on pneumococcal acute otitis media (AOM) by serotype. In Second International Symposium on Pneumococci and Pneumococcal Disease, Sun City, South Africa, March 19-23, abstract O20.
59. Konradsen, H.B., and Kaltoft, M.S. (2002) Invasive Pneumococcal Infections in Denmark from 1995 to 1999: Epidemiology, Serotypes, and Resistance. Clin. Diagn. Lab. Immunol. 9: 358-365.
60. Korchev, Y.E., Bashford, C.L., Pederzolli, C., Pasternak, C.A., Morgan, P.J., Andrew, P.W., and Mitchell, T.J. (1998) A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers. Biochem J 329 (Pt 3): 571-577.
61. Lau, G.W., Haataja, S., Lonetto, M., Kensit, S.E., Marra, A., Bryant, A.P., McDevitt, D., Morrison, D.A., and Holden, D.W. (2001) A functional genomic analysis of type 3 Streptococcus pneumoniae virulence. Mol Microbiol 40: 555-571.
62. Lawrence, M.C., Pilling, P.A., Epa, V.C., Berry, A.M., Ogunniyi, A.D., and Paton, J.C. (1998) The crytal structure of pneumococcal surface antigen PsaA reveals a metal-binding site and a novel structure for a putative ABC-type binding protein. Structure 6: 1553-1561.
63. Leimkugel, J., Adams Forgor, A., Gagneux, S., Pfluger, V., Flierl, C., Awine, E., Naegeli, M., Dangy, J.P., Smith, T., Hodgson, A., and Pluschke, G. (2005) An Outbreak of Serotype 1 Streptococcus pneumoniae Meningitis in Northern Ghana with Features That Are Characteristic of Neisseria meningitidis Meningitis Epidemics. J Infect Dis 192: 192-199.
64. Lipsitch, M. (1999) Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococus pneumoniae. Em. Inf. Dis. 5: 336-345.
65. Lock, R.A., Zhang, Q.Y., Berry, A.M., and Paton, J.C. (1996) Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretic mobility of the toxin. Microb Pathog 21: 71-83.
66. Madsen, M., Lebenthal, Y., Cheng, Q., Smith, B.L., and Hostetter, M.K. (2000) A pneumococcal protein that elicits interleukin-8 from pulmonary epithelial cells. Journal of Infectious Diseases 181: 1330-1336.
67. Malley, R., Henneke, P., Morse, S.C., Cieslewicz, M.J., Lipsitch, M., Thompson, C.M., Kurt-Jones, E., Paton, J.C., Wessels, M.R., and Golenbock, D.T. (2003) Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. PNAS: 0435928100.
68. Martens, P., Worm, S.W., Lundgren, B., Konradsen, H.B., and Benfield, T. (2004) Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis 4: 21.
69. McChlery, S.M., Scott, K.J., and Clarke, S.C. (2005) Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: possible implications for UK vaccine policy. Eur J Clin Microbiol Infect Dis.
70. Mcdaniel, L.S., Yother, J., Vijayakumar, M., Mcgarry, L., Guild, W.R., and Briles, D.E. (1987) Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein-a (pspa). Journal Of Experimental Medicine 165: 381-394.
71. McFarlane, A.C., Hamra, L.K., Reiss-Levy, E., and Hansman, D. (1979) Pneumococcal peritonitis in adolescent girls. Med J Aust 1: 100-101.
72. Mercat, A., Nguyen, J., and Dautzenberg, B. (1991) An outbreak of pneumococcal pneumonia in two men's shelters. Chest 99: 147-151.
73. Michon, F., Fusco, P.C., Minetti, C.A.S.A., Laude-Sharp, M., Uitz, C., Huang, C.-H., D'Ambra, A.J., Moore, S., Remeta, D.P., Heron, I., and Blake, M.S. (1998) Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein. Vaccine 16: 1732-1741.
74. Mitchell, T.J., Mendez, F., Paton, J.C., Andrew, P.W., and Boulnois, G.J. (1990) Comparison of pneumolysin genes and proteins from Streptococcus pneumoniae types 1 and 2. Nucleic Acids Res 18: 4010.
75. Neeleman, C., Geelen, S.P.M., Aerts, P.C., Daha, M.R., Mollnes, T.E., Roord, J.J., Posthuma, G., vanDijk, H., and Fleer, A. (1999) Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infection and Immunity 67: 4517-4524.
76. Obaro, S.K. (2000) Confronting the pneumococcus: a target shift or bullet change? Vaccine 19: 1211-1217.
77. Obaro, S.K. (2002) The new pneumococcal vaccine. Clin Microbial Infect 8: 623-633.
78. Paterson, G.K., and Mitchell, T.J. (2006) The role of Streptococcus pneumoniae sortase A in colonisation and pathogenesis. Microbes and Infection 8: 145-153.
79. Paton, J.C., and Ferrante, A. (1983) Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect. Immun. 41: 1212-1216.
80. Paton, J.C., Rowan-Kelly, B., and Ferrante, A. (1984) Activation of human complement by the pneumococcal toxin pneumolysin. Infect. Immun. 43: 1085-1087.
81. Paton, J.C., Lock, R.A., Lee, C.J., Li, J.P., Berry, A.M., Mitchell, T.J., Andrew, P.W., Hansman, D., and Boulnois, G.J. (1991) Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect Immun 59: 2297-2304.
82. Paton, J.C. (1996) The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae. Trends Microbiol 4: 103-106.
83. Pelton, S.I., Dagan, R., Gaines, B.M., Klugman, K.P., Laufer, D., O'Brien, K., and Schmitt, H.J. (2003) Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Vaccine 21: 1562-1571.
84. Polissi, A., Pontiggia, A., Feger, G., Altieri, M., Mottl, H., Ferrari, L., and Simon, D. (1998) Large-scale identification of virulence genes from Streptococcus pneumoniae. Infection and Immunity 66: 5620-5629.
85. Rosenow, C., Ryan, P., Weiser, J., Johnson, S., Fontan, P., Ortqvist, A., and Masure, H. (1997) Contribution of a Novel Choline Binding Protein to Adherence, Colonization, and Immunogenicity of Streptococcus pneumoniae. Molecular Microbiology 25: 819-829.
86. Rubins, J., Charboneau, D., Fasching, C., Berry, A., Paton, J., Alexander, J., Andrew, P., Mitchell, T., and Janoff, E. (1996a) Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am. J. Respir. Crit. Care Med. 153: 1339-1346.
87. Rubins, J.B., Duane, P.G., Charboneau, D., and Janoff, E.N. (1992) Toxicity of Pneumolysin to Pulmonary Endothelial Cells In Vitro. Infection and Immunity 60: 1740-1746.
88. Rubins, J.B., Duane, P.G., Clawson, D., Charboneau, D., Young, J., and Niewoehner, D.E. (1993) Toxicity of Pneumolysin to Pulmonary Alveolar Epithelial Cells. Infection and Immunity 61: 1352-1358.
89. Rubins, J.B., Mitchell, T.J., Andrew, P.W., and Niewoehner, D.E. (1994) Pneumolysin activates phospholipase A in pulmonary artery endothelial cells. Infection and Immunity 62: 3829-3836.
90. Rubins, J.B., Charboneau, D., Paton, J.C., Mitchell, T.J., Andrew, P.W., and Janoff, E.N. (1995) Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest 95: 142-150.
91. Rubins, J.B., Charboneau, D., Fasching, C., Berry, A.M., Paton, J.C., Alexander, J.E., Andrew, P.W., Mitchell, T.J., and Janoff, E.N. (1996b) Distinct role for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am. J. Respir. and Critical Care Medicine 153: 1339-1346.
92. Sirotnak, A.P., Eppes, S.C., and Klein, J.D. (1996) Tuboovarian abscess and peritonitis caused by Streptococcus pneumoniae serotype 1 in young girls. Clin Infect Dis 22: 993-996.
93. Smith, B.L., and Hostetter, M.K. (2000) C3 as substrate for adhesion of Streptococcus pneumoniae. J Infect Dis 182: 497-508.
94. Spratt, B.G., and Greenwood, B.M. (2000) Prevention of pneumococcal disease by vaccination: does serotype replacement matter? The Lancet 356: 1210-1211.
95. Srivastava, A., Henneke, P., Visintin, A., Morse, S.C., Martin, V., Watkins, C., Paton, J.C., Wessels, M.R., Golenbock, D.T., and Malley, R. (2005) The Apoptotic Response to Pneumolysin Is Toll-Like Receptor 4 Dependent and Protects against Pneumococcal Disease. Infect. Immun. 73: 6479-6487.
96. Steinfort, C., Wilson, R., Mitchell, T., Feldman, C., Rutman, A., Todd, H., Sykes, D., Walker, J., Saunders, K., Andrew, P.W., Boulnois, G.J., and Cole, P.J. (1989) Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infection and Immunity 57: 2006-2013.
97. Stringaris, A.K., Geisenhainer, J., Bergmann, F., Balshusemann, C., Lee, U., Zysk, G., Mitchell, T.J., Keller, B.U., Kuhnt, U., Gerber, J., Spreer, A., Bahr, M., Michel, U., and Nau, R. (2002) Neurotoxicity of Pneumolysin, a Major Pneumococcal Virulence Factor, Involves Calcium Influx and Depends on Activation of p38 Mitogen-Activated Protein Kinase. Neurobiol Dis 11: 355-368.
98. Tan, T.Q., Mason, E.O., Jr, Wald, E.R., Barson, W.J., Schutze, G.E., Bradley, J.S., Givner, L.B., Yogev, R., Kim, K.S., and Kaplan, S.L. (2002) Clinical Characteristics of Children With Complicated Pneumonia Caused by Streptococcus pneumoniae. Pediatrics 110: 1-6.
99. Tettelin, H., Nelson, K.E., Paulsen, I.T., Eisen, J.A., Read, T.D., Peterson, S., Heidelberg, J., DeBoy, R.T., Haft, D.H., Dodson, R.J., Durkin, A.S., Gwinn, M., Kolonay, J.F., Nelson, W.C., Peterson, J.D., Umayam, L.A., White, O., Salzberg, S.L., Lewis, M.R., Radune, D., Holtzapple, E., Khouri, H., Wolf, A.M., Utterback, T.R., Hansen, C.L., McDonald, L.A., Feldblyum, T.V., Angiuoli, S., Dickinson, T., Hickey, E.K., Holt, I.E., Loftus, B.J., Yang, F., Smith, H.O., Venter, J.C., Dougherty, B.A., Morrison, D.A., Hollingshead, S.K., and Fraser, C.M. (2001) Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293: 498-506.
100. Tong, H.H., Blue, L.E., James, M.A., and DeMaria, T.F. (2000) Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infection and Immunity 68: 921-924.
101. Tseng, H.-J., McEwan, A.G., Paton, J.C., and Jennings, M.P. (2002) Virulence of Streptococcus pneumoniae: PsaA Mutants Are Hypersensitive to Oxidative Stress. Infect. Immun. 70: 1635-1639.
102. Tu, A.T., Fulgham, R.L., McCrory, M.A., Briles, D.E., and Szalai, A.J. (1999) Pneumococcal Surface Protein A Inhibits Complement Activation by Streptococcus pneumoniae. Infection and Immunity 67: 4720-4724.
103. Tuomanen, E., Liu, H., Hengstler, B., Zak, O., and Tomasz, A. (1985) The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151: 859-868.
104. Tweten, R.K. (2005) Cholesterol-Dependent Cytolysins, a Family of Versatile Pore-Forming Toxins. Infect. Immun. 73: 6199-6209.
105. Westh, H., Skibsted, L., and Korner, B. (1990) Streptococcus pneumoniae infections of the female genital tract and in the newborn child. Rev Infect Dis 12: 416-422.
106. Winter, A.J., Comis, S.D., Osborne, M.P., Tarlow, M.J., Stephen, J., Andrew, P.W., Hill, J., and Mitchell, T.J. (1997) A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect. Immun. 65: 4411-4418.
107. Yesilkaya, H., Kadioglu, A., Gingles, N., Alexander, J.E., Mitchell, T.J., and Andrew, P.W. (2000) Role of manganese-containing superoxide dismutase in oxidative stress and virulence of Streptococcus pneumoniae. Infect Immun 68: 2819-2826.
108. Zhang, J.R., Mostov, K.E., Lamm, M.E., Nanno, M., Shimida, S., Ohwaki, M., and Tuomanen, E. (2000) The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102: 827-837.